Microbial transformation of sampangine

Area of Science:

• Microbiology
• Natural Product Chemistry
• Pharmacology

Background:

• Sampangine is an antifungal alkaloid with potential therapeutic applications.
• Understanding its metabolic fate is crucial for drug development and efficacy assessment.
• Microbial transformations offer a pathway to generate novel sampangine derivatives.

Purpose of the Study:

• To investigate the microbial metabolism of sampangine.
• To identify and characterize the resulting metabolites.
• To evaluate the in vitro and in vivo antifungal activity of these metabolites.

Main Methods:

• Standard two-stage fermentation technique using various microorganisms.
• Characterization of metabolites using spectral data.
• In vitro antifungal assays against Cryptococcus neoformans and Candida albicans.
• In vivo efficacy testing in a mouse model of cryptococcosis.

Main Results:

• Two major metabolites were identified: 4 -O-methyl-beta-glucopyranose conjugate (3) and beta-glucopyranose conjugate (4).
• Microorganisms like Beauvaria bassiana and Doratomyces microsporus produced conjugate 3.
• Absidia glauca and Cunninghamella elegans produced conjugate 4.
• Both metabolites 3 and 4 demonstrated significant in vitro activity against Cryptococcus neoformans.
• Metabolites 3 and 4 were inactive against Candida albicans.
• Metabolite 4 showed no activity in vivo against cryptococcosis in a mouse model.

Conclusions:

• Microbial transformation of sampangine yields distinct glucuronide conjugates.
• These metabolites possess selective in vitro antifungal activity against Cryptococcus neoformans.
• Further investigation into metabolite 3's in vivo potential may be warranted.
• Metabolite 4 lacks efficacy in a murine model of cryptococcosis.